TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema

Angela L. Bosma(Amsterdam University Medical Centers), Carsten Flohr(King's College London), David Prieto‐Merino(London School of Hygiene & Tropical Medicine), Jacob P. Thyssen(Bispebjerg Hospital), B.W.M. Arents(European Federation of Allergy and Airways Diseases Patients Associations), Dmitri Wall(Children's Health Ireland at Crumlin), Mette Deleuran(Aarhus University Hospital), Eulàlia Baselga(Hospital Sant Joan de Déu Barcelona), Falko Tesch(University Hospital Carl Gustav Carus), S. Barbarot(Hotel Dieu Hospital), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), M.A. Middelkamp‐Hup(Amsterdam University Medical Centers), I. García‐Doval(University Hospital Complex Of Vigo), Christian Vestergaard(Aarhus University), F.M. Vermeulen(Amsterdam University Medical Centers), Jochen Schmitt(University Hospital Carl Gustav Carus), Lawrence F. Eichenfield(University of California San Diego), Phyllis I. Spuls, Christian Apfelbacher(Heidelberg University), Tiago Torres(Universidade do Porto), Alan D. Irvine(Trinity College Dublin), Luigi Naldi(Centro Studi GISED), Julien Sénéschal(Hôpital Saint-André), Pedro Mendes‐Bastos(Hospital do Desterro), Amanda Roberts(University of Nottingham), Å. Svensson(Skåne University Hospital), S. Weidinger(University Hospital Schleswig-Holstein), L.B. von Kobyletzki(Lund University), Andrea Manca(University of Sassari)
British Journal of Dermatology
August 24, 2019
Cited by 25


Related Papers